ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 210 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,280,000,000 | -53.2% | 23,951 | -1.1% | 0.01% | -54.5% |
| Q4 2015 | $2,735,000,000 | +93886.3% | 24,207 | -2.1% | 0.01% | -15.4% |
| Q3 2015 | $2,910,000 | -99.8% | 24,726 | +1.1% | 0.01% | +62.5% |
| Q2 2015 | $1,894,326,000 | +53.0% | 24,465 | +14.3% | 0.01% | +60.0% |
| Q1 2015 | $1,237,817,000 | +82.4% | 21,397 | +1.7% | 0.01% | +66.7% |
| Q4 2014 | $678,766,000 | +23.7% | 21,047 | -6.1% | 0.00% | +50.0% |
| Q3 2014 | $548,520,000 | +43.6% | 22,416 | +4.0% | 0.00% | 0.0% |
| Q2 2014 | $382,028,000 | +10.8% | 21,547 | +25.1% | 0.00% | 0.0% |
| Q1 2014 | $344,772,000 | +22.2% | 17,230 | +2.5% | 0.00% | +100.0% |
| Q4 2013 | $282,172,000 | +56.4% | 16,816 | -1.0% | 0.00% | 0.0% |
| Q3 2013 | $180,381,000 | +189.9% | 16,985 | +52.6% | 0.00% | – |
| Q2 2013 | $62,217,000 | – | 11,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |